Literature DB >> 20443830

Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension.

Fares A Masri1, Suzy A A Comhair, Iva Dostanic-Larson, Francisco Takao Kaneko, Raed A Dweik, Alejandro C Arroliga, Serpil C Erzurum.   

Abstract

Idiopathic pulmonary arterial hypertension (IPAH) is associated with lower levels of the pulmonary vasodilator nitric oxide (NO) and its biochemical reaction products (nitrite [NO(2) (-)], nitrate [NO(3) (-)]), in part, due to the reduction in pulmonary endothelial NO synthesis. However, NO levels are also determined by consumptive reactions, such as with superoxide to form peroxynitrite, which subsequently may generate stable products of nitrotyrosine (Tyr-NO(2)) and/or NO(3) (-). In this context, superoxide dismutase (SOD) preserves NO in vivo by scavenging superoxide and preventing the consumptive reactions. Here, we hypothesized that reactive oxygen species (ROS) consumption of NO may contribute to the low NO level and development of pulmonary hypertension. To test this, nitrotyrosine and antioxidants glutathione (GSH), glutathione peroxidase (GPx), catalase, and SOD were evaluated in IPAH patients and healthy controls. SOD and GPx activities were decreased in IPAH lungs (all p < 0.05), while catalase and GSH activities were similar among the groups (all p > 0.2). SOD activity was directly related to exhaled NO (eNO) (R(2)= 0.72, p= 0.002), and inversely related to bronchoalveolar lavage (BAL) NO(3) (-) (R(2)=-0.73, p= 0.04). Pulmonary artery pressure (PAP) could be predicted by a regression model incorporating SOD, GPx, and NO(3) values (R(2)= 0.96, p= 0.01). These findings suggest that SOD and GPx are associated with alterations in NO and PAP in IPAH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20443830      PMCID: PMC5439561          DOI: 10.1111/j.1752-8062.2008.00035.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN: 1752-8054            Impact factor:   4.689


  54 in total

Review 1.  Primary pulmonary hypertension: update on pathogenesis and novel therapies.

Authors:  A C Arroliga; R A Dweik; F J Kaneko; S C Erzurum
Journal:  Cleve Clin J Med       Date:  2000-03       Impact factor: 2.321

2.  Proteomic method identifies proteins nitrated in vivo during inflammatory challenge.

Authors:  K S Aulak; M Miyagi; L Yan; K A West; D Massillon; J W Crabb; D J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

Review 3.  Molecular mechanisms involved in the reciprocal regulation of cyclooxygenase and nitric oxide synthase enzymes.

Authors:  S Cuzzocrea; D Salvemini
Journal:  Kidney Int       Date:  2007-01-03       Impact factor: 10.612

Review 4.  Strategies of antioxidant defense.

Authors:  H Sies
Journal:  Eur J Biochem       Date:  1993-07-15

5.  Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo.

Authors:  H R De Raeve; F B Thunnissen; F T Kaneko; F H Guo; M Lewis; M S Kavuru; M Secic; M J Thomassen; S C Erzurum
Journal:  Am J Physiol       Date:  1997-01

6.  Glutathione-related antioxidant defenses in human atherosclerotic plaques.

Authors:  D Lapenna; S de Gioia; G Ciofani; A Mezzetti; S Ucchino; A M Calafiore; A M Napolitano; C Di Ilio; F Cuccurullo
Journal:  Circulation       Date:  1998-05-19       Impact factor: 29.690

7.  Superoxide and peroxynitrite in atherosclerosis.

Authors:  C R White; T A Brock; L Y Chang; J Crapo; P Briscoe; D Ku; W A Bradley; S H Gianturco; J Gore; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Product of extracellular-superoxide dismutase catalysis.

Authors:  S L Marklund
Journal:  FEBS Lett       Date:  1985-05-20       Impact factor: 4.124

9.  Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats.

Authors:  Fumihiko Kamezaki; Hiromi Tasaki; Kazuhito Yamashita; Masato Tsutsui; Shinichiro Koide; Sei Nakata; Akihide Tanimoto; Masahiro Okazaki; Yasuyuki Sasaguri; Tetsuo Adachi; Yutaka Otsuji
Journal:  Am J Respir Crit Care Med       Date:  2007-10-25       Impact factor: 21.405

10.  Human copper-containing superoxide dismutase of high molecular weight.

Authors:  S L Marklund
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

View more
  27 in total

Review 1.  Redox biology in pulmonary arterial hypertension (2013 Grover Conference Series).

Authors:  Joshua P Fessel; James D West
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  An official American Thoracic Society Statement: pulmonary hypertension phenotypes.

Authors:  Raed A Dweik; Sharon Rounds; Serpil C Erzurum; Stephen Archer; Karen Fagan; Paul M Hassoun; Nicholas S Hill; Marc Humbert; Steven M Kawut; Michael Krowka; Evangelos Michelakis; Nicholas W Morrell; Kurt Stenmark; Rubin M Tuder; John Newman
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

Review 3.  Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review.

Authors:  Mohsen Imenshahidi; Golamreza Karimi; Hossein Hosseinzadeh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-01-30       Impact factor: 3.000

Review 4.  Role of reactive oxygen species in neonatal pulmonary vascular disease.

Authors:  Stephen Wedgwood; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 5.  Endothelial Cell Metabolism.

Authors:  Guy Eelen; Pauline de Zeeuw; Lucas Treps; Ulrike Harjes; Brian W Wong; Peter Carmeliet
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.

Authors:  Iwona Fijalkowska; Weiling Xu; Suzy A A Comhair; Allison J Janocha; Lori A Mavrakis; Balaji Krishnamachary; Lijie Zhen; Thianzi Mao; Amy Richter; Serpil C Erzurum; Rubin M Tuder
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

7.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

Review 8.  Molecular Basis of Nitrative Stress in the Pathogenesis of Pulmonary Hypertension.

Authors:  Colin E Evans; You-Yang Zhao
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Authors:  Juan Manuel Ramiro-Diaz; Carlos H Nitta; Levi D Maston; Simon Codianni; Wieslawa Giermakowska; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-03-08       Impact factor: 5.464

Review 10.  Reactive oxygen species in pulmonary vascular remodeling.

Authors:  Saurabh Aggarwal; Christine M Gross; Shruti Sharma; Jeffrey R Fineman; Stephen M Black
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.